Lin Jia, Han Jia, Yuan Fang, B. Yan, Mei Zhang, Yang Zhang, Wen Wang, Caiping Guo, Xiaojie Huang, Tong Zhang, Taiyi Jiang
What is already known about this topic? The prevalence of monkeypox (mpox) infections is primarily observed among young men who engage in sexual activities with other men, and there is a possibility of sexual transmission. Co-occurring sexually transmitted infections have also been documented. What is added by this report? In this report, we present a case of a patient in China who was simultaneously diagnosed with mpox, and acute human immunodeficiency virus (HIV) infection. The patient exhibited symptoms of fever and widespread papules on the trunk, face, and genital area. What are the implications for public health practice? It is crucial for health agencies to prioritize HIV testing when mpox is suspected or diagnosed in individuals with recent engagement in high-risk sexual behavior.
关于这一主题的已知信息有哪些？猴痘（mpox）感染主要发生在与其他男性发生性行为的年轻男性中，存在性传播的可能性。也有记录显示同时存在性传播感染。本报告增加了哪些内容？在本报告中，我们介绍了一例在中国同时被诊断出患有 mpox 和急性人类免疫缺陷病毒（HIV）感染的患者。患者表现出发热症状，躯干、面部和生殖器部位出现广泛丘疹。这对公共卫生实践有什么影响？当怀疑或确诊近期有高危性行为的人患有痘疹时，卫生机构必须优先进行 HIV 检测。
{"title":"A Case of Acute HIV-1 and Monkeypox Coinfection After Condomless Insertive Anal Sex in the Previous 69 Days — Beijing Municipality, China, August–October, 2023","authors":"Lin Jia, Han Jia, Yuan Fang, B. Yan, Mei Zhang, Yang Zhang, Wen Wang, Caiping Guo, Xiaojie Huang, Tong Zhang, Taiyi Jiang","doi":"10.46234/ccdcw2024.026","DOIUrl":"https://doi.org/10.46234/ccdcw2024.026","url":null,"abstract":"What is already known about this topic? The prevalence of monkeypox (mpox) infections is primarily observed among young men who engage in sexual activities with other men, and there is a possibility of sexual transmission. Co-occurring sexually transmitted infections have also been documented. What is added by this report? In this report, we present a case of a patient in China who was simultaneously diagnosed with mpox, and acute human immunodeficiency virus (HIV) infection. The patient exhibited symptoms of fever and widespread papules on the trunk, face, and genital area. What are the implications for public health practice? It is crucial for health agencies to prioritize HIV testing when mpox is suspected or diagnosed in individuals with recent engagement in high-risk sexual behavior.","PeriodicalId":505168,"journal":{"name":"China CDC Weekly","volume":"26 11","pages":"126 - 130"},"PeriodicalIF":0.0,"publicationDate":"2024-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139960698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Xinlong Wang, Zhixia Gu, Shugui Sheng, Rui Song, Ronghua Jin
On July 23, 2022, the World Health Organization (WHO) declared the monkeypox (mpox) outbreak a “Public Health Emergency of International Concern.” Since 2022, outbreaks of mpox in many countries around the world have primarily resulted in fatalities among immunocompromised individuals, such as untreated HIV/AIDS patients. Since the eradication of smallpox was declared by the WHO in 1980, the global vaccination against smallpox has been gradually discontinued. China also stopped routine smallpox vaccination in 1981. The protective effect of the smallpox vaccine has decreased over time due to aging and declining immunity in those who were vaccinated. For individuals, timely vaccination against smallpox is an effective means of protection against mpox. However, due to safety concerns with the smallpox vaccine and the limitations of current mpox vaccines, there is no vaccine that is safe, effective, and has low side effects applied in clinical settings. This article provides a comprehensive review of the development of mpox virus (MPXV) vaccines, their application in special populations, and the current state of vaccine research, considering the etiology, transmission, and prevention of the MPXV. Vaccination, as an effective method of epidemic prevention, can provide long-term immune protection and effectively reduce the severity of infection. However, as there is no licensed specific MPXV vaccine available globally, the vaccines currently used for mpox prevention are mostly smallpox vaccines. These smallpox vaccines can offer some degree of protection against mpox by activating cross-protection in the body.
{"title":"The Current State and Progress of Mpox Vaccine Research","authors":"Xinlong Wang, Zhixia Gu, Shugui Sheng, Rui Song, Ronghua Jin","doi":"10.46234/ccdcw2024.025","DOIUrl":"https://doi.org/10.46234/ccdcw2024.025","url":null,"abstract":"On July 23, 2022, the World Health Organization (WHO) declared the monkeypox (mpox) outbreak a “Public Health Emergency of International Concern.” Since 2022, outbreaks of mpox in many countries around the world have primarily resulted in fatalities among immunocompromised individuals, such as untreated HIV/AIDS patients. Since the eradication of smallpox was declared by the WHO in 1980, the global vaccination against smallpox has been gradually discontinued. China also stopped routine smallpox vaccination in 1981. The protective effect of the smallpox vaccine has decreased over time due to aging and declining immunity in those who were vaccinated. For individuals, timely vaccination against smallpox is an effective means of protection against mpox. However, due to safety concerns with the smallpox vaccine and the limitations of current mpox vaccines, there is no vaccine that is safe, effective, and has low side effects applied in clinical settings. This article provides a comprehensive review of the development of mpox virus (MPXV) vaccines, their application in special populations, and the current state of vaccine research, considering the etiology, transmission, and prevention of the MPXV. Vaccination, as an effective method of epidemic prevention, can provide long-term immune protection and effectively reduce the severity of infection. However, as there is no licensed specific MPXV vaccine available globally, the vaccines currently used for mpox prevention are mostly smallpox vaccines. These smallpox vaccines can offer some degree of protection against mpox by activating cross-protection in the body.","PeriodicalId":505168,"journal":{"name":"China CDC Weekly","volume":"44 8","pages":"118 - 125"},"PeriodicalIF":0.0,"publicationDate":"2024-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139961612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yan Kui, Shuai Han, Xiaojuan Zhang, Guangzhong Shi, Yale Yu, Ruirui Li, Peizheng Zhan, Hongju Duan, Wenbo Luo, Benfu Li, Shaoqi Ning, Yalan Zhang, Aiya Zhu, J. Xue
What is already known about this topic? Echinococcosis is classified as a Class C infectious disease in China. It is endemic in 370 counties located in the agricultural and pastoral regions of western China. What is added by this report? This report provides a comprehensive overview of the cases of echinococcosis reported in China in 2022. Following a thorough evaluation conducted by provincial CDCs, it was identified that 105 new cases were not reported through the National Notifiable Disease Reporting System. Furthermore, there were 1,051 cases that were reported among patients who had been previously diagnosed with echinococcosis. What are the implications for public health practice? The reported cases of echinococcosis in non-endemic counties of provincial-level administrative divisions where the disease is endemic need to be given more attention, as there is a potential risk of it spreading within the non-endemic areas. Inadequate reporting practices by clinical medical institutions are hindering the subsequent investigations carried out by CDCs. It is important to implement enhanced health promotion efforts that focus on high-risk populations to address unhealthy lifestyles.
{"title":"Analysis of Epidemiological and Issues Encountered in Case Reports on Echinococcosis — China, 2022","authors":"Yan Kui, Shuai Han, Xiaojuan Zhang, Guangzhong Shi, Yale Yu, Ruirui Li, Peizheng Zhan, Hongju Duan, Wenbo Luo, Benfu Li, Shaoqi Ning, Yalan Zhang, Aiya Zhu, J. Xue","doi":"10.46234/ccdcw2024.022","DOIUrl":"https://doi.org/10.46234/ccdcw2024.022","url":null,"abstract":"What is already known about this topic? Echinococcosis is classified as a Class C infectious disease in China. It is endemic in 370 counties located in the agricultural and pastoral regions of western China. What is added by this report? This report provides a comprehensive overview of the cases of echinococcosis reported in China in 2022. Following a thorough evaluation conducted by provincial CDCs, it was identified that 105 new cases were not reported through the National Notifiable Disease Reporting System. Furthermore, there were 1,051 cases that were reported among patients who had been previously diagnosed with echinococcosis. What are the implications for public health practice? The reported cases of echinococcosis in non-endemic counties of provincial-level administrative divisions where the disease is endemic need to be given more attention, as there is a potential risk of it spreading within the non-endemic areas. Inadequate reporting practices by clinical medical institutions are hindering the subsequent investigations carried out by CDCs. It is important to implement enhanced health promotion efforts that focus on high-risk populations to address unhealthy lifestyles.","PeriodicalId":505168,"journal":{"name":"China CDC Weekly","volume":"50 19","pages":"100 - 104"},"PeriodicalIF":0.0,"publicationDate":"2024-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139964943","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Wenbo Hu, Yijin Chen, Ying Liang, Tianyun Su, Qiyong Liu, Xuewen Li, Xiaobo Liu
What is already known about this topic? Anopheles sinensis (An. sinensis) is the predominant malaria vector in China. The impact of S-methoprene on the emergence process of mosquito larvae suggests its potential as a control method for vector mosquitoes. However, the efficacy of S-methoprene in controlling An. sinensis has not yet been demonstrated. What is added by this report? The effectiveness of S-methoprene against An. sinensis was assessed in laboratory and semi-field conditions in Yunnan Province. What are the implications for public health practice? These results offer valuable options and guidance for utilizing S-methoprene products in malaria reimportation prevention areas within Yunnan Province.
{"title":"Laboratory and Semi-Field Evaluation on S-Methoprene Formulations Against Anopheles sinensis (Diptera: Culicidae) — Yuxi City, Yunnan Province, China","authors":"Wenbo Hu, Yijin Chen, Ying Liang, Tianyun Su, Qiyong Liu, Xuewen Li, Xiaobo Liu","doi":"10.46234/ccdcw2024.023","DOIUrl":"https://doi.org/10.46234/ccdcw2024.023","url":null,"abstract":"What is already known about this topic? Anopheles sinensis (An. sinensis) is the predominant malaria vector in China. The impact of S-methoprene on the emergence process of mosquito larvae suggests its potential as a control method for vector mosquitoes. However, the efficacy of S-methoprene in controlling An. sinensis has not yet been demonstrated. What is added by this report? The effectiveness of S-methoprene against An. sinensis was assessed in laboratory and semi-field conditions in Yunnan Province. What are the implications for public health practice? These results offer valuable options and guidance for utilizing S-methoprene products in malaria reimportation prevention areas within Yunnan Province.","PeriodicalId":505168,"journal":{"name":"China CDC Weekly","volume":"43 10","pages":"105 - 108"},"PeriodicalIF":0.0,"publicationDate":"2024-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139964992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Y. Hao, Tian Tian, Zelin Zhu, Yijun Chen, Jing Xu, Shuai Han, Menbao Qian, Yi Zhang, Shizhu Li, Qiang Wang
{"title":"Accelerating the Control and Elimination of Major Parasitic Diseases in China — On World NTD Day 2024","authors":"Y. Hao, Tian Tian, Zelin Zhu, Yijun Chen, Jing Xu, Shuai Han, Menbao Qian, Yi Zhang, Shizhu Li, Qiang Wang","doi":"10.46234/ccdcw2024.021","DOIUrl":"https://doi.org/10.46234/ccdcw2024.021","url":null,"abstract":"","PeriodicalId":505168,"journal":{"name":"China CDC Weekly","volume":"49 8","pages":"95 - 99"},"PeriodicalIF":0.0,"publicationDate":"2024-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139964709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：